17 15 Amba Health and Care Limited 12608913 false 2024-01-01 2024-12-31 2024-12-31 The principal activity of the company is is that of providing healthcare services Digita Accounts Production Advanced 6.30.9574.0 true false true 12608913 2024-01-01 2024-12-31 12608913 2024-12-31 12608913 bus:OrdinaryShareClass1 bus:CumulativeNon-redeemableShares 2024-12-31 12608913 bus:OrdinaryShareClass2 bus:CumulativeNon-redeemableShares 2024-12-31 12608913 bus:OrdinaryShareClass3 bus:CumulativeNon-redeemableShares 2024-12-31 12608913 core:CurrentFinancialInstruments 2024-12-31 12608913 core:CurrentFinancialInstruments core:WithinOneYear 2024-12-31 12608913 core:Non-currentFinancialInstruments core:AfterOneYear 2024-12-31 12608913 core:Goodwill 2024-12-31 12608913 core:AdditionsToInvestments 2024-12-31 12608913 core:CostValuation 2024-12-31 12608913 core:FurnitureFittings 2024-12-31 12608913 core:OfficeEquipment 2024-12-31 12608913 core:PlantMachinery 2024-12-31 12608913 core:KeyManagementPersonnelCloseFamilyMembersEntitiesUnderKeyManagementPersonnelsControl 2024-12-31 12608913 core:OtherRelatedParties 2024-12-31 12608913 bus:SmallEntities 2024-01-01 2024-12-31 12608913 bus:AuditExemptWithAccountantsReport 2024-01-01 2024-12-31 12608913 bus:FilletedAccounts 2024-01-01 2024-12-31 12608913 bus:SmallCompaniesRegimeForAccounts 2024-01-01 2024-12-31 12608913 bus:RegisteredOffice 2024-01-01 2024-12-31 12608913 bus:Director1 2024-01-01 2024-12-31 12608913 bus:OrdinaryShareClass1 bus:CumulativeNon-redeemableShares 2024-01-01 2024-12-31 12608913 bus:OrdinaryShareClass2 bus:CumulativeNon-redeemableShares 2024-01-01 2024-12-31 12608913 bus:OrdinaryShareClass3 bus:CumulativeNon-redeemableShares 2024-01-01 2024-12-31 12608913 bus:PrivateLimitedCompanyLtd 2024-01-01 2024-12-31 12608913 core:Goodwill 2024-01-01 2024-12-31 12608913 core:FurnitureFittings 2024-01-01 2024-12-31 12608913 core:OfficeEquipment 2024-01-01 2024-12-31 12608913 core:PlantMachinery 2024-01-01 2024-12-31 12608913 core:KeyManagementPersonnel 2024-01-01 2024-12-31 12608913 core:KeyManagementPersonnelCloseFamilyMembersEntitiesUnderKeyManagementPersonnelsControl 2024-01-01 2024-12-31 12608913 core:OtherRelatedParties 2024-01-01 2024-12-31 12608913 countries:EnglandWales 2024-01-01 2024-12-31 12608913 2023-12-31 12608913 core:Goodwill 2023-12-31 12608913 core:CostValuation 2023-12-31 12608913 core:FurnitureFittings 2023-12-31 12608913 core:OfficeEquipment 2023-12-31 12608913 core:PlantMachinery 2023-12-31 12608913 core:KeyManagementPersonnelCloseFamilyMembersEntitiesUnderKeyManagementPersonnelsControl 2023-12-31 12608913 core:OtherRelatedParties 2023-12-31 12608913 2023-01-01 2023-12-31 12608913 2023-12-31 12608913 bus:OrdinaryShareClass1 bus:CumulativeNon-redeemableShares 2023-12-31 12608913 bus:OrdinaryShareClass2 bus:CumulativeNon-redeemableShares 2023-12-31 12608913 bus:OrdinaryShareClass3 bus:CumulativeNon-redeemableShares 2023-12-31 12608913 core:CurrentFinancialInstruments 2023-12-31 12608913 core:CurrentFinancialInstruments core:WithinOneYear 2023-12-31 12608913 core:Non-currentFinancialInstruments core:AfterOneYear 2023-12-31 12608913 core:FurnitureFittings 2023-12-31 12608913 core:OfficeEquipment 2023-12-31 12608913 core:PlantMachinery 2023-12-31 12608913 core:KeyManagementPersonnelCloseFamilyMembersEntitiesUnderKeyManagementPersonnelsControl 2023-12-31 12608913 core:OtherRelatedParties 2023-12-31 12608913 core:KeyManagementPersonnelCloseFamilyMembersEntitiesUnderKeyManagementPersonnelsControl 2023-01-01 2023-12-31 12608913 core:OtherRelatedParties 2023-01-01 2023-12-31 12608913 2022-12-31 12608913 core:KeyManagementPersonnelCloseFamilyMembersEntitiesUnderKeyManagementPersonnelsControl 2022-12-31 12608913 core:OtherRelatedParties 2022-12-31 xbrli:pure iso4217:GBP xbrli:shares

Registration number: 12608913

Amba Health and Care Limited

Annual Report and Unaudited Financial Statements

for the Year Ended 31 December 2024

 

Amba Health and Care Limited

Contents

Balance Sheet

1 to 2

Notes to the Unaudited Financial Statements

3 to 11

 

Amba Health and Care Limited

(Registration number: 12608913)
Balance Sheet as at 31 December 2024

Note

2024
£

(As restated)

2023
£

Fixed assets

 

Tangible assets

5

9,269

14,928

Investments

6

1,587,787

85,675

 

1,597,056

100,603

Current assets

 

Stocks

7

96,353

50,143

Debtors

8

586,314

88,632

Cash at bank and in hand

 

227,478

69,534

 

910,145

208,309

Creditors: Amounts falling due within one year

9

(192,111)

(2,346,873)

Net current assets/(liabilities)

 

718,034

(2,138,564)

Total assets less current liabilities

 

2,315,090

(2,037,961)

Provisions for liabilities

-

(1,888)

Net assets/(liabilities)

 

2,315,090

(2,039,849)

Capital and reserves

 

Called up share capital

11

287

293

Share premium reserve

7,065,846

882,827

Retained earnings

(4,751,043)

(2,922,969)

Shareholders' funds/(deficit)

 

2,315,090

(2,039,849)

 

Amba Health and Care Limited

(Registration number: 12608913)
Balance Sheet as at 31 December 2024

For the financial year ending 31 December 2024 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.

Directors' responsibilities:

The members have not required the company to obtain an audit of its accounts for the year in question in accordance with section 476; and

The directors acknowledge their responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.

These financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime. As permitted by section 444 (5A) of the Companies Act 2006, the directors have not delivered to the registrar a copy of the Profit and Loss Account.

Approved and authorised by the Board on 23 December 2025 and signed on its behalf by:
 

S J Hamilton
Director

   
     
 

Amba Health and Care Limited

Notes to the Unaudited Financial Statements for the Year Ended 31 December 2024

1

General information

The company is a private company limited by share capital, incorporated in England and Wales.

The address of its registered office is:
71-75 Shelton Street
London
Greater London
WC2H 9JQ

These financial statements were authorised for issue by the Board on 23 December 2025.

2

Accounting policies

Summary of significant accounting policies and key accounting estimates

The principal accounting policies applied in the preparation of these financial statements are set out below. These policies have been consistently applied to all the years presented, unless otherwise stated.

Statement of compliance

These financial statements have been prepared in accordance with Financial Reporting Standard 102 Section 1A smaller entities - 'The Financial Reporting Standard applicable in the United Kingdom and Republic of Ireland' and the Companies Act 2006 (as applicable to companies subject to the small companies' regime).

Basis of preparation

These financial statements have been prepared using the historical cost convention.

The financial statements are prepared in sterling, which is the functional and presentational currency of the company, and rounded to the nearest £.

Group accounts not prepared

The company has chosen not to prepare consolidated accounts as it is exempt under section 399 of the Companies Act by being a parent of a small group.

Going concern

The financial statements have been prepared on a going concern basis. As at the date of signing the financial statements, the directors confirm that the company is in a position to meet its liabilities for a period of 12 months and that there are no foreseeable events which may give rise to liabilities which exceeds the company’s ability to pay.

 

Amba Health and Care Limited

Notes to the Unaudited Financial Statements for the Year Ended 31 December 2024

Prior period errors

During preparation of the financial statements for the current year, it was identified that amortisation on goodwill had been written back against the value of investments in error. The prior period balance sheet and notes have been restated to correct this error. The effect of this restatement on the prior period is to increase the value of investments by £213,940 and decrease the value of goodwill by £213,940.

Additionally, it was identified that investments in subsidiaries and loans and borrowings had been remeasured to fair value via the revaluation reserve in error, since these amounts are actually recognised at amortised cost in line with the company's accounting policies. The prior period balance sheet and notes have been restated to correct this error. The effect of this restatement on the prior period is to decrease the value of the revaluation reserve by £215,578, decrease the value of investments by £21,396, and increase the value of loans and borrowings by £194,182.

Revenue recognition

Revenue comprises the fair value of the consideration received or receivable for the sale of goods and for the provision of services in the ordinary course of the company’s activities. Revenue is shown net of sales/value added tax, returns, rebates and discounts.

The company recognises revenue for the sale of goods when all the following conditions are satisfied:
a) the significant risks and rewards of ownership have been transferred to the buyer;
b) the group retains no continuing involvement or control over the goods;
c) the amount of revenue can be reliably measured;
d) it is probable that future economic benefits will flow to the company; and
e) specific criteria have been met for each of the groups activities.

The company recognises revenue from the provision of services in the period in which the services are provided in accordance with the stage of completion of the contract when all of the following conditions are satisfied:
a) the amount of revenue can be reliably measured;
b) it is probable that future economic benefit will flow to the company;
c) the stage of completion of the contract at the end of the reporting period can be reliably measured; and
d) the costs incurred and the costs to complete the contract can be reliably measured.
 

Government grants

Government grants are recognised when it is reasonable to expect that the grants will be received
and that all related conditions will be met, usually on submission of a valid claim or payment.

Government grants in respect of capital expenditure are credited to a deferred income account and
are released to profit over the expected useful lives of the relevant assets by equal annual
instalments.
Grants of a revenue nature are credited to income so as to match them with the expenditure to which
they relate.

Finance income and costs policy

Interest income and expenses are recognised using the effective interest rate method.

 

Amba Health and Care Limited

Notes to the Unaudited Financial Statements for the Year Ended 31 December 2024

Foreign currency transactions and balances

Transactions in foreign currencies are initially recorded at the functional currency rate prevailing at the date of the transaction. Monetary assets and liabilities denominated in foreign currencies are retranslated into the respective functional currency of the entity at the rates prevailing on the reporting period date. Non-monetary items carried at fair value that are denominated in foreign currencies are retranslated at the rate on the date when the fair value is re-measured.

Non-monetary items measured in terms of historical cost in a foreign currency are not retranslated.

Tangible assets

Tangible assets are stated in the Balance Sheet at cost, less any subsequent accumulated depreciation and subsequent accumulated impairment losses.

The cost of tangible assets includes directly attributable incremental costs incurred in their acquisition and installation.

Depreciation

Depreciation is charged so as to write off the cost of assets, other than land and properties under construction over their estimated useful lives, as follows:

Asset class

Depreciation method and rate

Plant and machinery

Straight line over 3 - 4 years

Fixtures and fittings

Straight line over 2 - 3 years

Computer equipment

Straight line over 2 - 4 years

Business combinations

Business combinations are accounted for using the purchase method. The consideration for each acquisition is measured at the aggregate of the fair values at acquisition date of assets given, liabilities incurred or assumed, and equity instruments issued by the group in exchange for control of the acquired, plus any costs directly attributable to the business combination. When a business combination agreement provides for an adjustment to the cost of the combination contingent on future events, the group includes the estimated amount of that adjustment in the cost of the combination at the acquisition date if the adjustment is probable and can be measured reliably.

Goodwill

Goodwill arising on the acquisition of an entity represents the excess of the cost of acquisition over the company’s interest in the net fair value of the identifiable assets, liabilities and contingent liabilities of the entity recognised at the date of acquisition. Goodwill is initially recognised as an asset at cost and is subsequently measured at cost less accumulated amortisation and accumulated impairment losses. Goodwill is held in the currency of the acquired entity and revalued to the closing rate at each reporting period date. Goodwill is amortised over its useful life, which shall not exceed ten years if a reliable estimate of the useful life cannot be made.

Development costs

Research expenditure and development costs are written off against profits in the year in which they are incurred.

Amortisation

Amortisation is provided on intangible assets so as to write off the cost, less any estimated residual value, over their useful life as follows:

Asset class

Amortisation method and rate

Goodwill

Straight line over 3 years

 

Amba Health and Care Limited

Notes to the Unaudited Financial Statements for the Year Ended 31 December 2024

Investments

Investments in equity shares which are publicly traded or where the fair value can be measured reliably are initially measured at fair value, with changes in fair value recognised in profit or loss. Investments in equity shares which are not publicly traded and where fair value cannot be measured reliably are measured at cost less impairment.

Interest income on debt securities, where applicable, is recognised in income using the effective interest method. Dividends on equity securities are recognised in income when receivable.

Cash and cash equivalents

Cash and cash equivalents comprise cash on hand and call deposits, and other short-term highly liquid investments that are readily convertible to a known amount of cash and are subject to an insignificant risk of change in value.

Debtors

Trade debtors are amounts due from customers for merchandise sold or services performed in the ordinary course of business.

Trade debtors are recognised initially at the transaction price. They are subsequently measured at amortised cost using the effective interest method, less provision for impairment. A provision for the impairment of trade debtors is established when there is objective evidence that the company will not be able to collect all amounts due according to the original terms of the receivables.

Stocks

Stocks are stated at the lower of cost and estimated selling price less costs to complete and sell. Cost is determined using the first-in, first-out (FIFO) method.

The cost of finished goods and work in progress comprises direct materials and, where applicable, direct labour costs and those overheads that have been incurred in bringing the stocks to their present location and condition. At each reporting date, stocks are assessed for impairment. If stocks are impaired, the carrying amount is reduced to its selling price less costs to complete and sell; the impairment loss is recognised immediately in profit or loss.

Creditors

Trade creditors are obligations to pay for goods or services that have been acquired in the ordinary course of business from suppliers. Trade creditors are classified as current liabilities if the company does not have an unconditional right, at the end of the reporting period, to defer settlement of the creditor for at least twelve months after the reporting date. If there is an unconditional right to defer settlement for at least twelve months after the reporting date, they are presented as non-current liabilities.

Trade creditors are recognised initially at the transaction price and subsequently measured at amortised cost using the effective interest method.

 

Amba Health and Care Limited

Notes to the Unaudited Financial Statements for the Year Ended 31 December 2024

Borrowings

Interest-bearing borrowings are initially recorded at fair value, net of transaction costs. Interest-bearing borrowings are subsequently carried at amortised cost, with the difference between the proceeds, net of transaction costs, and the amount due on redemption being recognised as a charge to the profit and loss account over the period of the relevant borrowing.

Interest expense is recognised on the basis of the effective interest method and is included in interest payable and similar charges.

Borrowings are classified as current liabilities unless the company has an unconditional right to defer settlement of the liability for at least twelve months after the reporting date.

Share capital

Ordinary shares are classified as equity. Equity instruments are measured at the fair value of the cash or other resources received or receivable, net of the direct costs of issuing the equity instruments. If payment is deferred and the time value of money is material, the initial measurement is on a present value basis.

Defined contribution pension obligation

A defined contribution plan is a pension plan under which fixed contributions are paid into a pension fund and the company has no legal or constructive obligation to pay further contributions even if the fund does not hold sufficient assets to pay all employees the benefits relating to employee service in the current and prior periods.

Contributions to defined contribution plans are recognised as employee benefit expense when they are due. If contribution payments exceed the contribution due for service, the excess is recognised as a prepayment.

3

Staff numbers

The average number of persons employed by the company (including directors) during the year was 17 (2023 - 15).

4

Intangible assets

Goodwill
 £

Total
£

Cost or valuation

At 1 January 2024

213,940

213,940

At 31 December 2024

213,940

213,940

Amortisation

At 1 January 2024 (as restated)

213,940

213,940

At 31 December 2024

213,940

213,940

Carrying amount

At 31 December 2024

-

-

 

Amba Health and Care Limited

Notes to the Unaudited Financial Statements for the Year Ended 31 December 2024

5

Tangible assets

Plant and machinery
£

Fixtures & fittings
£

Computer equipment
£

Total
£

Cost or valuation

At 1 January 2024

2,515

462

26,270

29,247

Additions

484

-

4,067

4,551

At 31 December 2024

2,999

462

30,337

33,798

Depreciation

At 1 January 2024

2,196

184

11,939

14,319

Charge for the year

480

184

9,546

10,210

At 31 December 2024

2,676

368

21,485

24,529

Carrying amount

At 31 December 2024

323

94

8,852

9,269

At 31 December 2023

319

278

14,331

14,928

6

Investments

2024
£

(As restated)

2023
£

Investments in subsidiaries

1,587,787

85,675

Subsidiaries

£

Cost or valuation

At 1 January 2024 (as restated)

85,675

Additions

1,502,112

At 31 December 2024

1,587,787

Carrying amount

At 31 December 2024

1,587,787

At 31 December 2023

85,675

 

Amba Health and Care Limited

Notes to the Unaudited Financial Statements for the Year Ended 31 December 2024

7

Stocks

2024
£

2023
£

Other inventories

96,353

50,143

8

Debtors

Note

2024
£

2023
£

Trade debtors

 

4,935

9,562

Amounts owed by related parties

13

500,431

-

Other debtors

 

24,000

27,297

Prepayments

 

56,948

48,937

Deferred tax assets

-

2,836

   

586,314

88,632

Less non-current portion

 

-

(2,836)

 

586,314

85,796

Details of non-current trade and other debtors

£Nil (2023 - £2,836) of deferred tax assets is classified as non current.

9

Creditors

Due within one year

Note

2024
£

(As restated)

2023
£

 

Loans and borrowings

10

-

1,892,646

Trade creditors

 

19,917

30,843

Amounts due to related parties

13

121,483

377,962

Social security and other taxes

 

37,974

33,187

Other creditors

 

6,662

7,944

Accruals

 

6,075

4,291

 

192,111

2,346,873

 

Amba Health and Care Limited

Notes to the Unaudited Financial Statements for the Year Ended 31 December 2024

10

Loans and borrowings

Current loans and borrowings

Note

2024
£

(As restated)

2023
£

Other borrowings

13

-

1,892,646

11

Share capital

Allotted, called up and fully paid shares

2024

2023

No.

£

No.

£

Ordinary of £0.0001 each

1,872,000

187

595,500

60

Ordinary A of £0.0001 each

1,000,000

100

1,000,000

100

Ordinary B of £0.0001 each

-

-

1,335,000

134

2,872,000

287

2,930,500

293

12

Financial commitments, guarantees and contingencies

Amounts not provided for in the balance sheet

The total amount of financial commitments not included in the balance sheet is £9,938 (2023 - £25,840).

Amounts disclosed in the balance sheet

Included in the balance sheet are outstanding pension liabilities of £6,077 (2023 - £7,162).

 

Amba Health and Care Limited

Notes to the Unaudited Financial Statements for the Year Ended 31 December 2024

13

Related party transactions

Summary of transactions with other related parties

Other related parties are comprised of shareholders of the company.

Loans to related parties

2024

Other related parties
£

Total
£

Advanced

500,431

500,431

At end of period

500,431

500,431

Terms of loans to related parties

Amounts due from other related parties are interest free and repayable on demand.

Loans from related parties

2024

Key management
£

Other related parties
£

Total
£

At start of period

377,962

1,892,646

2,270,608

Advanced

50,375

-

50,375

Repaid

(306,854)

(1,892,646)

(2,199,500)

At end of period

121,483

-

121,483

2023 (as restated)

Key management
£

Other related parties
£

Total
£

At start of period

182,962

-

182,962

Advanced

195,000

1,892,646

2,087,646

At end of period

377,962

1,892,646

2,270,608

Terms of loans from related parties

Amounts due to key management are interest free and repayable on demand.
 Amounts due to other related parties are interest free and repayable on demand.